Pasithea Therapeutics Corp.
KTTA
Last
$0.47
Day
+6.0%
1y
-44.2%
5y
-99.2%
52w
-78.6%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
2026-11-1232d
EMA 21
0.48
EMA 50
0.51
EMA 200
0.69
20d high
-19.8%
5y high
-99.7%
5y range
0th
Positions held
Your positionsKTTA isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-24
Hold
avoid
Signal
Strong Sell
Target
$0.50
Stop
$0.39
Stop distance
16.6%
Target vs last
+7.0%
Fundamentals
| Market cap | $14.73M | Enterprise value | -$30.93M | Trailing P/E | — | Forward P/E | -0.96 |
| PEG | — | Price / book | 0.30 | Beta | 0.34 | Dividend yield | 0.00% |
| Revenue growth | — | Earnings growth | — | Gross margin | 0.0% | Operating margin | 0.0% |
| Profit margin | 0.0% | ROE | -65.5% | ROA | -36.0% | Debt / equity | — |
| Current ratio | 26.25 | Free cash flow | -$12.17M | Analyst recommendation | none | Mean target | $3.00 |
| 52w high | $2.06 | 52w low | $0.28 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — | — |
| Net income | -$5.3M | -$2.9M | -$10.1M | -$3.0M | -$3.7M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | -$5.7M | -$4.9M | -$10.3M | -$3.1M | -$3.8M | — |
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $0.0M | $0.0M | $0.0M | $0.0M | — |
| Op margin | — | — | — | — | — |
| Net income | -$20.4M | -$13.9M | -$16.0M | -$13.9M | — |
| Gross margin | — | — | — | — | — |
| Gross profit | — | — | — | $0.4M | -$0.0M |
| Operating income | -$20.9M | -$14.2M | -$16.0M | -$12.6M | — |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsKTTA · daily-14.2% over 13 sessions
Close EMA21 EMA50 EMA200
Quarterly · revenue, net income, margins
Revenue Net income Gross margin Op margin